Literature DB >> 4084172

Effects of psychotropic drugs on thermal responses to radiofrequency radiation.

J R Jauchem, M R Frei, F Heinmets.   

Abstract

An increase in body temperature is a primary effect of exposure to high levels of radiofrequency radiation; therefore, pharmacological agents which may modify thermoregulation are of interest. The present study investigated the effects of chlorpromazine, amitriptyline, and haloperidol on thermal responses in anesthetized rats exposed to 2.8 GHz radiofrequency radiation. Exposure was performed at an average power density of 60 mW X cm-2 (average whole body absorption rate, 14 W X kg-1), and was of sufficient duration to increase colonic temperature from 38.5 to 39.5 degrees C. Administration of chlorpromazine (5 mg X kg-1) resulted in a slower rate of colonic temperature rise during radiation exposure and a faster return to baseline temperature when exposure was discontinued. Administration of amitriptyline (10 mg X kg-1), haloperidol (0.1 mg X kg-1), or saline did not significantly affect thermal responses. A more rhythmic pattern of respiration occurred following chlorpromazine administration; the change in pattern was not seen after amitriptyline, haloperidol, or saline administration. The results indicate that acute administration of chlorpromazine can counteract hyperthermia during exposure to radiofrequency radiation, when colonic temperature is not allowed to rise above 39.5 degrees C.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4084172

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  2 in total

1.  Thermoregulatory responses of rats exposed to 9.3-GHz radiofrequency radiation.

Authors:  M R Frei; J R Jauchem; F Heinmets
Journal:  Radiat Environ Biophys       Date:  1989       Impact factor: 1.925

2.  Emerging synergisms between drugs and physiologically-patterned weak magnetic fields: implications for neuropharmacology and the human population in the twenty-first century.

Authors:  P D Whissell; M A Persinger
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.